Neovacs, the human polyclonal antibodies company. Our scientists work to develop vaccines aigainst chronic diseases, such as AIDS, cancer, allergy and autoimmunity
 

You could meet Neovacs people at these events :


• ACR
(American College of Rheumatology)
Annual Meeting,
November 6-11, 2007
Boston (MA), USA

• ASCO
(American Society of Clinical Oncology)
Annual Meeting,
June 1-5, 2007
Chicago (IL), USA
 
• 8th International Congress of SLE (Lupus)
May 23-27, 2007
Shanghai, CHINA

• 4th International Conference on Tumor Microenvironment,
March 6-10, 2007
Florence, Italy

 




• 6th Genesis Conference
December 12, 2006
London, UK

• ACR (American College of Rheumatology)
Annual Meeting,
November 11-15, 2006
Washington DC, USA

• 6th Annual Biotech in Europe Investor Forum
October 4-5, 2006
Zurich, SWITZERLAND

• Euro-Biotech Forum
June 27-29, 2006
Paris, FRANCE

• Red Herring Venture Market Europe
May 8-10, 2006
Paris, FRANCE

• BIOSQUARE
March 8-10, 2006
Geneva, SWITZERLAND
Paris, October 10th, 2007 :
Neovacs anti-IL4 active immunization and control of allergic reactions in mice published in the Vaccine journal ... Read More
Paris, July 17th, 2007 :
Neovacs raises 13 million Euro equity with NOVARTIS Venture Fund as lead investor... Read More
Paris, February 22nd, 2007 :
Neovacs anti-VEGF vaccination preclinical proof-of-concept in solid-tumor animal models published in PNAS... Read More
Shanghai, May 23-27th, 2007 :
Neovacs and Inserm units U543 & U764  present the preclinical proof-of-concept of "IFN-alpha Kinoid" anti-IFN-alpha vaccine in a NZB/NZW F1 lupus prone mice model... Read More

Paris, December 19th, 2006 :
Neovacs anti-TNF-alpha vaccination proof-of-concept in animal models of TNF-alpha overproduction associated pathologies published in PNAS ... Read More
Paris, July 11th, 2006 :
Neovacs receives milestone payment from Debiopharm for TNF-alpha Kinoid® in cancer cachexia and autoimmune diseases... Read More
Paris, June 6th, 2006 :
Neovacs Appoints Guy-Charles Fanneau de La Horie as New Chief Executive Officer.... Read More
Paris, May 9th, 2006 :
Neovacs is recognized as one of the most promising biotechnology companies
in Europe and Israel.... Read More



site map